kr11.10
5.71%
Stockholm, Oct 06, 04:04 pm CEST. Market open.
Why the stock moved Why the stock moved Beta
ISIN
SE0007074166
Symbol
NANEXA

Nanexa Stock price

kr10.50
+4.38 71.57% 1M
+6.77 181.50% 6M
+6.05 135.96% YTD
+8.40 398.81% 1Y
+9.52 975.82% 3Y
+6.64 172.02% 5Y
+1.86 21.53% 10Y
+1.86 21.53% 20Y
Stockholm, Closing price Mon, Oct 05 2026
+0.51 5.11%
ISIN
SE0007074166
Symbol
NANEXA

Is Nanexa a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,121 stocks worldwide.

Key metrics

Basic
Market capitalization
kr1.9b
Enterprise Value
kr1.9b
Net debt
positive
Cash
kr52.6m
Shares outstanding
191.0m
Valuation
P/E
negative
P/S | estimate
56.4 | -
EV/Sales | estimate
54.9 | -
EV/FCF | ex SBC
negative | -
P/B
14.4
Financial Health
Equity Ratio
73.5%
Return on Equity
-11.2%
ROCE
-17.1%
ROIC
-28.0%
Debt/Equity
0.0
Financials
Revenue | estimate
kr33.9m | -
EBITDA
kr-9.8m
EBIT
kr-22.8m
Net Income
kr-24.6m
Free Cash Flow | ex SBC
kr-33.8m | -
Growth
Revenue | estimate
104.8% | -
EBITDA
45.7%
EBIT
24.0%
Net Income
20.7%
Free Cash Flow
38.6%
Margin
Gross
78.2%
EBITDA
-28.9%
EBIT
-67.4%
Net
-72.5%
Free Cash Flow | ex SBC
-99.7% | -
More
EPS
kr-0.1
FCF per Share
kr-0.2
Short interest
-
Employees
16
Rev per Employee
kr2.3m

Financial data from Nanexa

Jun '26
+/-
%
34 34
105% 105%
100%
- Direct Costs 7.40 7.40
410% 410%
22%
26 26
75% 75%
78%
- Selling and Administrative Expenses 23 23
6% 6%
67%
- Research and Development Expense - -
-
-
-9.79 -9.79
46% 46%
-29%
- Depreciation and Amortization 13 13
8% 8%
38%
EBIT (Operating Income) EBIT -23 -23
24% 24%
-67%
Net Profit -25 -25
21% 21%
-73%

In millions SEK.

Don't miss a Thing! We will send you all news about Nanexa directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Nanexa AB engages in the development, production, and distribution of medical nanotechnology products. The firm specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

Head office Sweden
CEO David Westberg
Employees 16
Website nanexa.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today